• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体外,同种异体抗原和名义抗原诱导的 CD8+ T 细胞反应中的肽交叉反应具有相似性。

A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro.

机构信息

Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Immunogenetics. 2013 Mar;65(3):173-84. doi: 10.1007/s00251-012-0668-3. Epub 2012 Dec 12.

DOI:10.1007/s00251-012-0668-3
PMID:23233149
Abstract

Raising tumor-specific allorestricted T cells in vitro for adoptive transfusion is expected to circumvent host tumor tolerance. However, it has been assumed that alloreactive T cell clones activated in vitro ranges from peptide-specific with high avidity to peptide-degenerate with low avidity. In this study, we examined the peptide specificity and cross-reactivity of T cell responses in vitro to an allogeneic epitope and a nominal epitope with a modified co-culture of lymphocytes and autologous monocytes. After binding to the monocyte via the interaction of its Fc part and the cell surface IgG Fc receptor type I (FcγRI), a fusion protein consisting of the extracellular domains of HLA-A2 molecule and the Fc region of IgG1 (the dimer) introduced a single epitope into the co-culture. The dimer-coated monocytes stimulated the proliferation of autologous CD8(+) T cells after co-culturing. The CD8(+) T cell responses were self-HLA-restricted for HLA-A2-positive (HLA-A2+ve) samples and allo-HLA-restricted for HLA-A2-negative (HLA-A2-ve) samples, since the co-cultural bulks stained with HLA-A2 tetramers, human interferon-gamma (IFN-γ) production in response to T cell receptor (TCR) ligands, and cytotoxicity against a panel of target cells exhibited peptide-specific properties. Two HLA-A2-restricted peptides with sequence homology were included, allowing the comparison of cross-reactivity between allo-antigen- and nominal antigen-induced CD8(+) T cell responses. Interestingly, the allo- and self-HLA-restricted CD8(+) T cell responses were similar in the peptide cross-reactivity, although the allorestricted T cell response seemed, overall, more intensive and had higher binding affinity to specific tetramer. Our findings indicated the alloreactive T cells raised by the co-culture in vitro were as peptide specific and cross-reactive as the self-HLA-restricted ones.

摘要

体外培养肿瘤特异性同种异体限制性 T 细胞有望规避宿主肿瘤耐受。然而,据假设,体外激活的同种反应性 T 细胞克隆的范围从高亲和力的肽特异性到低亲和力的肽非特异性。在这项研究中,我们检查了体外同种异体表位和修饰的共培养淋巴细胞和自体单核细胞的名义表位的 T 细胞反应的肽特异性和交叉反应性。融合蛋白由 HLA-A2 分子的细胞外结构域和 IgG1 的 Fc 区(二聚体)组成,通过其 Fc 部分与细胞表面 IgG Fc 受体 I(FcγRI)的相互作用与单核细胞结合,将单个表位引入共培养物中。二聚体包被的单核细胞在共培养后刺激自体 CD8+T 细胞的增殖。CD8+T 细胞反应对于 HLA-A2 阳性(HLA-A2+ve)样本是自 HLA 限制的,对于 HLA-A2 阴性(HLA-A2-ve)样本是同种 HLA 限制的,因为共培养物用 HLA-A2 四聚体染色,对 TCR 配体的人类干扰素-γ(IFN-γ)产生和对一系列靶细胞的细胞毒性均表现出肽特异性。包含两个具有序列同源性的 HLA-A2 限制性肽,允许比较同种抗原和名义抗原诱导的 CD8+T 细胞反应之间的交叉反应性。有趣的是,尽管同种异体限制性 T 细胞反应总体上似乎更强烈并且对特定四聚体具有更高的结合亲和力,但同种异体和自体 HLA 限制性 CD8+T 细胞反应在肽交叉反应性方面是相似的。我们的研究结果表明,体外共培养物中产生的同种反应性 T 细胞与自体 HLA 限制的 T 细胞一样具有肽特异性和交叉反应性。

相似文献

1
A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro.在体外,同种异体抗原和名义抗原诱导的 CD8+ T 细胞反应中的肽交叉反应具有相似性。
Immunogenetics. 2013 Mar;65(3):173-84. doi: 10.1007/s00251-012-0668-3. Epub 2012 Dec 12.
2
Allo-restricted CTLs generated by coculturing of PBLs and autologous monocytes loaded with allogeneic peptide/HLA/IgG1-Fc fusion protein.通过将外周血淋巴细胞(PBLs)与负载同种异体肽/HLA/IgG1-Fc融合蛋白的自体单核细胞共培养产生的同种异体限制性细胞毒性T淋巴细胞(CTLs)。
J Leukoc Biol. 2009 Mar;85(3):574-81. doi: 10.1189/jlb.0408242. Epub 2008 Dec 26.
3
Raising allo-restricted cytotoxic T lymphocytes by co-culture of murine splenocytes with autologous macrophage bearing the peptide/allo-major histococompatibility complex.通过将小鼠脾细胞与携带肽/同种异体主要组织相容性复合体的自体巨噬细胞共培养来培养同种异体限制性细胞毒性T淋巴细胞。
Hum Immunol. 2009 Feb;70(2):79-84. doi: 10.1016/j.humimm.2008.11.005. Epub 2008 Dec 25.
4
Peptide-specific, allogeneic T cell response in vitro induced by a self-peptide binding to HLA-A2.与HLA - A2结合的自身肽在体外诱导的肽特异性同种异体T细胞反应。
Sci China C Life Sci. 2007 Apr;50(2):203-11. doi: 10.1007/s11427-007-0036-y.
5
Tumor rejection effects of allorestricted tumor peptide-specific CD4(+) T cells on human cervical cancer cell xenograft in nude mice.同种异体限制的肿瘤肽特异性 CD4(+) T 细胞对裸鼠人宫颈癌异种移植瘤的肿瘤排斥作用。
Cell Transplant. 2012;21(7):1503-14. doi: 10.3727/096368912X640510.
6
Longitudinal analysis of Mycobacterium tuberculosis 19-kDa antigen-specific T cells in patients with pulmonary tuberculosis: association with disease activity and cross-reactivity to a peptide from HIVenv gp120.肺结核患者中结核分枝杆菌19-kDa抗原特异性T细胞的纵向分析:与疾病活动的关联以及对HIV env gp120肽段的交叉反应性
Eur J Immunol. 2003 Jun;33(6):1613-23. doi: 10.1002/eji.200323480.
7
The avidity of cross-reactive virus-specific T cells for their viral and allogeneic epitopes is variable and depends on epitope expression.交叉反应性病毒特异性T细胞对其病毒表位和同种异体表位的亲和力是可变的,并且取决于表位的表达。
Hum Immunol. 2018 Jan;79(1):39-50. doi: 10.1016/j.humimm.2017.10.019. Epub 2017 Oct 31.
8
Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens.检测和定量分析对与HLA - A2.1结合的黑色素瘤和病毒肽抗原产生反应的分泌肿瘤坏死因子α的血液源性CD8 + T淋巴细胞。
J Immunol Methods. 1996 May 27;191(2):131-42. doi: 10.1016/0022-1759(96)00007-5.
9
Peptide-dependent inhibition of alloreactive T-cell response by soluble divalent HLA-A2/IgG molecule in vitro.可溶性二价 HLA-A2/IgG 分子在体外对同种异体反应性 T 细胞应答的肽依赖性抑制作用。
Transplantation. 2007 Nov 27;84(10):1298-306. doi: 10.1097/01.tp.0000288231.97880.bd.
10
Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers.利用重组HLA I类多聚体研究肽在T细胞同种异体识别中的作用。
J Immunol. 2005 Aug 1;175(3):1706-14. doi: 10.4049/jimmunol.175.3.1706.

引用本文的文献

1
A strategy to reconstitute immunity without GVHD via adoptive allogeneic Tscm therapy.通过过继性同种异体 Tscm 治疗重建无移植物抗宿主病的免疫策略。
Front Immunol. 2024 Jul 5;15:1367609. doi: 10.3389/fimmu.2024.1367609. eCollection 2024.
2
Antigen-specific CD8+ memory stem T cells generated from human peripheral blood effectively eradicate allogeneic targets in mice.从人外周血中产生的抗原特异性 CD8+ 记忆干 T 细胞可有效清除小鼠中的同种异体靶标。
Stem Cell Res Ther. 2018 Dec 7;9(1):337. doi: 10.1186/s13287-018-1080-1.
3
Puerarin alleviates delayed-type hypersensitivity via cytokine inhibition by modulating Th1/Th2 balance.

本文引用的文献

1
High determinant density may explain the phenomenon of alloreactivity.高决定簇密度可能解释同种异体反应性现象。
Immunol Today. 1984 May;5(5):128-30. doi: 10.1016/0167-5699(84)90233-0.
2
TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition.T 细胞受体交叉反应性和同种异体识别:同种异体识别免疫遗传学的新见解。
Immunogenetics. 2012 Feb;64(2):77-85. doi: 10.1007/s00251-011-0590-0. Epub 2011 Dec 3.
3
Allo-HLA-reactive T cells inducing graft-versus-host disease are single peptide specific.同种异体 HLA 反应性 T 细胞诱导移植物抗宿主病具有单肽特异性。
葛根素通过调节Th1/Th2平衡抑制细胞因子,从而减轻迟发型超敏反应。
Exp Ther Med. 2018 May;15(5):4441-4447. doi: 10.3892/etm.2018.5990. Epub 2018 Mar 22.
Blood. 2011 Dec 22;118(26):6733-42. doi: 10.1182/blood-2011-05-354787. Epub 2011 Oct 4.
4
Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity.用编码同种异体主要组织相容性复合体(MHC)和抗原的RNA脉冲处理的树突状细胞可诱导具有卓越抗肿瘤活性和更高T细胞受体(TCR)功能亲和力的T细胞。
Blood. 2009 Sep 3;114(10):2131-9. doi: 10.1182/blood-2009-03-209387. Epub 2009 Jul 8.
5
Preclinical development of T cell receptor gene therapy.T细胞受体基因疗法的临床前开发。
Curr Opin Immunol. 2009 Apr;21(2):209-14. doi: 10.1016/j.coi.2009.02.007. Epub 2009 Mar 25.
6
Allo-restricted CTLs generated by coculturing of PBLs and autologous monocytes loaded with allogeneic peptide/HLA/IgG1-Fc fusion protein.通过将外周血淋巴细胞(PBLs)与负载同种异体肽/HLA/IgG1-Fc融合蛋白的自体单核细胞共培养产生的同种异体限制性细胞毒性T淋巴细胞(CTLs)。
J Leukoc Biol. 2009 Mar;85(3):574-81. doi: 10.1189/jlb.0408242. Epub 2008 Dec 26.
7
Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.通过定量质谱分析揭示的非TAP依赖性MHC I类配体的特征
Eur J Immunol. 2008 Jun;38(6):1503-10. doi: 10.1002/eji.200838136.
8
T-cell receptor gene therapy of established tumors in a murine melanoma model.小鼠黑色素瘤模型中已形成肿瘤的T细胞受体基因治疗
J Immunother. 2008 Jan;31(1):1-6. doi: 10.1097/CJI.0b013e31815c193f.
9
Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes.同种反应性T细胞对多种不同的肽-MHC复合物产生特异性反应。
Nat Immunol. 2007 Apr;8(4):388-97. doi: 10.1038/ni1446. Epub 2007 Feb 25.
10
A simplified PCR-SSP method for HLA-A2 subtype in a population of Wuhan, China.一种用于中国武汉人群中HLA - A2亚型的简化聚合酶链反应-序列特异性引物(PCR - SSP)方法。
Cell Mol Immunol. 2006 Dec;3(6):453-8.